Sagimet Biosciences, Inc. (SGMT)
5.96
-0.10
(-1.65%)
USD |
NASDAQ |
Dec 26, 16:00
5.95
-0.01
(-0.17%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly): 128.40M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Madrigal Pharmaceuticals, Inc. | 1.362B |
| HCA Healthcare, Inc. | 59.75B |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.146M |
| Shareholders Equity (Quarterly) | 119.26M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 13.04 |
| Net Debt Paydown Yield | 0.00% |